Recombinant Mouse UBE3A Protein (HEK293)，Flag & Myc

UBE3A, also known as ubiquitin-protein ligase E3A, is a crucial protein implicated in regulating protein degradation through the ubiquitin-proteasome pathway. Its research is particularly significant in the context of Angelman syndrome, a neurodevelopmental disorder caused by the loss of function of the UBE3A gene, primarily inherited from the mother. In neurons, UBE3A is subject to genomic imprinting, which means that the paternal allele is typically silenced, leading to the manifestation of symptoms when the maternal allele is mutated or deleted. This unique mechanism has made UBE3A a focal point for understanding not only Angelman syndrome but also broader implications in neurodevelopmental disorders and brain function. Researchers have been exploring the structure and function of UBE3A, aiming to elucidate its role in synaptic regulation, learning, and memory. Recent advances in gene editing technologies, such as CRISPR/Cas9, have opened new avenues for potential therapeutic interventions, including the reactivation of the paternal UBE3A allele. By generating recombinant UBE3A proteins, scientists are investigating their interactions, post-translational modifications, and overall impact on neuronal health. Overall, UBE3A research is critical for uncovering the underlying mechanisms of Angelman syndrome and developing targeted therapies to alleviate its effects, ultimately contributing to our understanding of neurodevelopmental conditions and their treatment.